https://www.globenewswire.com/news-release/2022/04/19/2424383/0/en/AUM-Biosciences-and-HANDOK-Presented-Phase-1-Data-for-AUM-601-at-ESMO-Targeted-Anticancer-Therapies-Congress-2022.html
AUM Biosciences and HANDOK Presented Phase 1 Data for
SINGAPORE and SEOUL, South Korea, April 19, 2022 (GLOBE NEWSWIRE) -- AUM Biosciences, a global clinical-stage biotech company, focused on discovering and...
aumbioscienceshandokpresentedphase